Barrington, RI, United States of America

Jisu Li

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Rhode Island Hospital, a Lifespan-Partner. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jisu Li: Innovator in Hepatitis B Treatment

Introduction

Jisu Li is a notable inventor based in Barrington, Rhode Island. He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis B virus infections. His innovative approach has the potential to improve the lives of many individuals affected by this virus.

Latest Patents

Jisu Li holds a patent for a method of treating hepatitis B virus infections by administering receptor associated protein (RAP). The specification of this patent provides compositions and methods aimed at reducing the risk of HBV infection in a subject and treating those already infected with HBV. This patent highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Li is currently affiliated with Rhode Island Hospital, a partner of Lifespan. His work at this esteemed institution allows him to collaborate with other professionals in the medical field and contribute to groundbreaking research and treatment methodologies.

Collaborations

Some of Jisu Li's coworkers include Jack Raymond Wands and Shuping Tong. Their collaboration fosters an environment of innovation and shared knowledge, which is essential for advancing research in hepatitis B treatment.

Conclusion

Jisu Li's contributions to the field of medicine, particularly through his patent on hepatitis B treatment, demonstrate his dedication to improving healthcare. His work at Rhode Island Hospital further emphasizes his role as a key innovator in this critical area of research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…